GB862242A - Resin-drug salts - Google Patents
Resin-drug saltsInfo
- Publication number
- GB862242A GB862242A GB30335/58A GB3033558A GB862242A GB 862242 A GB862242 A GB 862242A GB 30335/58 A GB30335/58 A GB 30335/58A GB 3033558 A GB3033558 A GB 3033558A GB 862242 A GB862242 A GB 862242A
- Authority
- GB
- United Kingdom
- Prior art keywords
- morphine
- resin
- drug
- dihydromorphinone
- divinyl benzene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 229940079593 drug Drugs 0.000 title abstract 5
- 239000003814 drug Substances 0.000 title abstract 5
- 150000003839 salts Chemical class 0.000 title 1
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 abstract 6
- MYRTYDVEIRVNKP-UHFFFAOYSA-N 1,2-Divinylbenzene Chemical compound C=CC1=CC=CC=C1C=C MYRTYDVEIRVNKP-UHFFFAOYSA-N 0.000 abstract 4
- 229960005181 morphine Drugs 0.000 abstract 3
- OROGSEYTTFOCAN-DNJOTXNNSA-N codeine Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC OROGSEYTTFOCAN-DNJOTXNNSA-N 0.000 abstract 2
- USSIQXCVUWKGNF-UHFFFAOYSA-N 6-(dimethylamino)-4,4-diphenylheptan-3-one Chemical compound C=1C=CC=CC=1C(CC(C)N(C)C)(C(=O)CC)C1=CC=CC=C1 USSIQXCVUWKGNF-UHFFFAOYSA-N 0.000 abstract 1
- OGDVEMNWJVYAJL-LEPYJNQMSA-N Ethyl morphine Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OCC OGDVEMNWJVYAJL-LEPYJNQMSA-N 0.000 abstract 1
- OGDVEMNWJVYAJL-UHFFFAOYSA-N Ethylmorphine Natural products C1C(N(CCC234)C)C2C=CC(O)C3OC2=C4C1=CC=C2OCC OGDVEMNWJVYAJL-UHFFFAOYSA-N 0.000 abstract 1
- GVGLGOZIDCSQPN-PVHGPHFFSA-N Heroin Chemical compound O([C@H]1[C@H](C=C[C@H]23)OC(C)=O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4OC(C)=O GVGLGOZIDCSQPN-PVHGPHFFSA-N 0.000 abstract 1
- JAQUASYNZVUNQP-USXIJHARSA-N Levorphanol Chemical compound C1C2=CC=C(O)C=C2[C@]23CCN(C)[C@H]1[C@@H]2CCCC3 JAQUASYNZVUNQP-USXIJHARSA-N 0.000 abstract 1
- XADCESSVHJOZHK-UHFFFAOYSA-N Meperidine Chemical compound C=1C=CC=CC=1C1(C(=O)OCC)CCN(C)CC1 XADCESSVHJOZHK-UHFFFAOYSA-N 0.000 abstract 1
- ONBWJWYUHXVEJS-ZTYRTETDSA-N Normorphine Chemical compound C([C@@H](NCC1)[C@@H]2C=C[C@@H]3O)C4=CC=C(O)C5=C4[C@@]21[C@H]3O5 ONBWJWYUHXVEJS-ZTYRTETDSA-N 0.000 abstract 1
- 229920002845 Poly(methacrylic acid) Polymers 0.000 abstract 1
- 239000004793 Polystyrene Substances 0.000 abstract 1
- 229930013930 alkaloid Natural products 0.000 abstract 1
- 229960004126 codeine Drugs 0.000 abstract 1
- 229960002069 diamorphine Drugs 0.000 abstract 1
- 229960004578 ethylmorphine Drugs 0.000 abstract 1
- LLPOLZWFYMWNKH-CMKMFDCUSA-N hydrocodone Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)CC(=O)[C@@H]1OC1=C2C3=CC=C1OC LLPOLZWFYMWNKH-CMKMFDCUSA-N 0.000 abstract 1
- 229960000240 hydrocodone Drugs 0.000 abstract 1
- OROGSEYTTFOCAN-UHFFFAOYSA-N hydrocodone Natural products C1C(N(CCC234)C)C2C=CC(O)C3OC2=C4C1=CC=C2OC OROGSEYTTFOCAN-UHFFFAOYSA-N 0.000 abstract 1
- WVLOADHCBXTIJK-YNHQPCIGSA-N hydromorphone Chemical compound O([C@H]1C(CC[C@H]23)=O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O WVLOADHCBXTIJK-YNHQPCIGSA-N 0.000 abstract 1
- 229960001410 hydromorphone Drugs 0.000 abstract 1
- 229960003406 levorphanol Drugs 0.000 abstract 1
- 229960001797 methadone Drugs 0.000 abstract 1
- NPZXCTIHHUUEEJ-CMKMFDCUSA-N metopon Chemical compound O([C@@]1(C)C(=O)CC[C@@H]23)C4=C5[C@@]13CCN(C)[C@@H]2CC5=CC=C4O NPZXCTIHHUUEEJ-CMKMFDCUSA-N 0.000 abstract 1
- 229950006080 metopon Drugs 0.000 abstract 1
- 229950006134 normorphine Drugs 0.000 abstract 1
- 229960000482 pethidine Drugs 0.000 abstract 1
- YNPNZTXNASCQKK-UHFFFAOYSA-N phenanthrene Chemical group C1=CC=C2C3=CC=CC=C3C=CC2=C1 YNPNZTXNASCQKK-UHFFFAOYSA-N 0.000 abstract 1
- 229920002223 polystyrene Polymers 0.000 abstract 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-N sulfonic acid Chemical group OS(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F8/00—Chemical modification by after-treatment
- C08F8/44—Preparation of metal salts or ammonium salts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
- A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BE582651A BE582651A (fr) | 1958-09-23 | 1959-09-14 | Procédé de préparation d'un composé de médicament |
| FR804550A FR659M (enrdf_load_stackoverflow) | 1958-09-23 | 1960-08-31 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH6471558A CH389829A (de) | 1958-10-06 | 1958-10-06 | Verfahren zur Herstellung einer Arzneimittelverbindung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB862242A true GB862242A (en) | 1961-03-08 |
Family
ID=4525850
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB30335/58A Expired GB862242A (en) | 1958-09-23 | 1958-09-23 | Resin-drug salts |
Country Status (3)
| Country | Link |
|---|---|
| BE (1) | BE636812A (enrdf_load_stackoverflow) |
| CH (1) | CH389829A (enrdf_load_stackoverflow) |
| GB (1) | GB862242A (enrdf_load_stackoverflow) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997037680A1 (en) * | 1996-04-05 | 1997-10-16 | The Board Of Trustees Of The University Of Illinois | Macromolecular complexes for drug delivery |
| US5935599A (en) * | 1996-10-28 | 1999-08-10 | The Board Of Trustees Of The University Of Illinois | Polymer-associated liposomes for drug delivery and method of manufacturing the same |
| US6417237B1 (en) * | 2000-06-08 | 2002-07-09 | The Board Of Trustees Of The University Of Illinois | Macromolecular drug complexes and compositions containing the same |
| WO2002028917A3 (en) * | 2000-10-06 | 2002-09-26 | Robert C Corcoran | Resin and its use in converting morphine to codeine |
| US7655256B2 (en) | 2001-09-17 | 2010-02-02 | Rohm And Haas Company | Pharmaceutical formulation including a resinate and an aversive agent |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5403595A (en) * | 1991-05-07 | 1995-04-04 | Dynagen, Inc. | Controlled, sustained release delivery system for smoking cessation |
| US5780051A (en) * | 1992-04-02 | 1998-07-14 | Dynagen, Inc. | Methods and articles of manufacture for nicotine cessation and monitoring nicotine use |
-
0
- BE BE636812D patent/BE636812A/xx unknown
-
1958
- 1958-09-23 GB GB30335/58A patent/GB862242A/en not_active Expired
- 1958-10-06 CH CH6471558A patent/CH389829A/de unknown
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997037680A1 (en) * | 1996-04-05 | 1997-10-16 | The Board Of Trustees Of The University Of Illinois | Macromolecular complexes for drug delivery |
| US6063370A (en) * | 1996-04-05 | 2000-05-16 | The Board Of Trustees Of The University Of Illinois | Macromolecular complexes for drug delivery |
| US5935599A (en) * | 1996-10-28 | 1999-08-10 | The Board Of Trustees Of The University Of Illinois | Polymer-associated liposomes for drug delivery and method of manufacturing the same |
| US6417237B1 (en) * | 2000-06-08 | 2002-07-09 | The Board Of Trustees Of The University Of Illinois | Macromolecular drug complexes and compositions containing the same |
| WO2002028917A3 (en) * | 2000-10-06 | 2002-09-26 | Robert C Corcoran | Resin and its use in converting morphine to codeine |
| US7655256B2 (en) | 2001-09-17 | 2010-02-02 | Rohm And Haas Company | Pharmaceutical formulation including a resinate and an aversive agent |
Also Published As
| Publication number | Publication date |
|---|---|
| CH389829A (de) | 1965-03-31 |
| BE636812A (enrdf_load_stackoverflow) |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Iwamoto et al. | Circling behavior and stereotypy induced by intranigral opiate microinjections. | |
| Wei et al. | Comparison of the behavioral effects of β-endorphin and enkephalin analogs | |
| FR2318895A1 (fr) | Dispersions aqueuses de resines olefiniques et leur preparation | |
| NL7710534A (nl) | Toevoerinrichting voor een aantal vloeistoffen ten gebruike bij een apparaat om een mengsel van deze vloeistoffen te ejecteren. | |
| GB862242A (en) | Resin-drug salts | |
| NL7609273A (nl) | Naaldhouderinrichting van een medische toedieninspuitinrichting. | |
| FR2300578A1 (fr) | Dispositif d'injection de medicaments | |
| NL185446C (nl) | Werkwijze voor de bereiding van een farmaceutisch preparaat te gebruiken als inhalatie-aerosol. | |
| GB1390772A (en) | Oral narcotic composition | |
| NL142073B (nl) | Werkwijze voor de bereiding van een, een hydroxyalkylcellulose als drager bevattend, gevormd geneesmiddel en aldus verkregen gevormd geneesmiddel. | |
| GB841697A (en) | Analgesic compositions | |
| NZ181239A (en) | Anaesthetic administering device retractable needle | |
| Preininger | The pharmacology and toxicology of the papaveraceae alkaloids | |
| IT1059015B (it) | Metodo di preparzione di un ca talizzatore di nichel voluminoso attivato | |
| AU2023276A (en) | Production of stable, aqueous emulsions of water - insoluble substances | |
| GB1183403A (en) | Antitussive Medicament with Prolonged Effect | |
| FR3152M (fr) | N-alkyl- et n-arylalkyl-benzoxacyclo-alkane-carboxamides comme analgésiques et hypotenseurs. | |
| Jackson | Beta-phenylethylamine and locomotor activity in mice. Interaction with catecholaminergic neurones and receptors | |
| FR378M (fr) | Médicament a base de 2-amino-7-méthyl-5-n-propyl-s-triazolo-[2,3-c]-pyrimidine a titre de bronchodilatateur. | |
| GB824337A (en) | Therapeutic compositions | |
| GB894609A (en) | Tannates of morphine alkaloids | |
| GB926584A (en) | Analgesic compositions comprising a benzamide derivative | |
| ES369337A1 (es) | Procedimiento para la fabricacion de nuevos medicamentos antiespasmodicos, antiarritmicos, antipireticos y antimala- ricos de accion prolongada. | |
| GB839507A (en) | Improvements relating to hypodermic equipment | |
| BE885330A (fr) | Nouveau medicament a action analgesique a base d'un 4,5,6,7-tetrahydro-isoxazolo (5,4-c) pyridine-3-ol |